Chloe Douglas-Crampton
Nessuna posizione attualmente
Health Technology
Storia della carriera di Chloe Douglas-Crampton
Precedenti posizioni note di Chloe Douglas-Crampton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Public Communications Contact | 01/11/2004 | - |
| Segretario Aziendale | 19/10/2009 | - |
Statistiche
Distribuzione geografica
| Canada | 2 |
Posizioni
| Public Communications Contact | 1 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
